Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sales & Earnings In Brief

This article was originally published in The Tan Sheet

Executive Summary

NBTY's net income plummets: Dietary supplement manufacturer and marketer NBTY's net sales grew 12 percent to $596 million in its second quarter, but higher material costs and the impact of a stronger U.S. dollar drove the firm's net income down 91.3 percent to $23 million. According to an April 23 earnings release, the Ronkonkoma, N.Y.-based firm's wholesale/U.S. nutrition division saw sales growth of 35 percent to $349.8 million. NBTY's European retail business dropped 15 percent to $134.4 million, its direct response and online sales were down 6 percent to $59.4 million and its North American retail sales were flat at $51.9 million as the LeNaturiste Canadian retail chain lost $800,000 in the January-March period. The sales total included $23 million from Julian Graves, although NBTY's acquisition of the U.K. retailer continues to be the subject of an inquiry from the U.K. Competition Commission for potential antitrust implications. NBTY also owns the Holland & Barrett retail vitamin and supplement chain in the U.K. Chief Financial Officer Harvey Kamil said NBTY has not proposed a plan to U.K. regulators for changing the Julian Graves operation. "Our goal is to keep the chain and operate the chain just like all the other chains that we have," Kamil said in an April 24 earnings call. Leiner Health Products, which NBTY acquired in July 2008, has been fully integrated into the firm and its sales are no longer separately broken out
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS102855

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel